Naira Essam Abou-Ghali

Naira Essam Abou-Ghali

Auto-generated profile, based on publicly available information

Naira Essam Abou-Ghali

Department of Medicine, Weill Cornell Medical College

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in eLife
Verified
Journal Article
Open access
SKSeaho Kim
Seaho Kim
CACheukMan C Au
CheukMan C Au
MJMohd Azrin Bin Jamalruddin
Mohd Azrin Bin Jamalruddin
NANaira Essam Abou-Ghali
Naira Essam Abou-Ghali
EMEiman Mukhtar
Eiman Mukhtar
PGParaskevi Giannakakou
Paraskevi Giannakakou
Expression of the AR splice variant, androgen receptor variant 7 (AR-V7), in prostate cancer is correlated with poor patient survival and resistance to AR targeted therapies and taxanes. Currently, there is no specific inhibitor of AR-V7, while the molecular mechanisms regulating its biological function are not well elucidated. Here, we report that AR-V7 has unique biological features that functionally differentiate it from canonical AR-fl or from the second most prevalent variant, AR-v567. First, AR-V7 exhibits fast nuclear import kinetics via a pathway distinct from the nuclear localization signal dependent importin-α/β pathway used by AR-fl and AR-v567. We also show that the dimerization box domain, known to mediate AR dimerization and transactivation, is required for AR-V7 nuclear import but not for AR-fl. Once in the nucleus, AR-V7 is transcriptionally active, yet exhibits unusually high intranuclear mobility and transient chromatin interactions, unlike the stable chromatin association of liganded AR-fl. The high intranuclear mobility of AR-V7 together with its high transcriptional output, suggest a Hit-and-Run mode of transcription. Our findings reveal unique mechanisms regulating AR-V7 activity, offering the opportunity to develop selective therapeutic interventions.